FDA Adverse Event Malfunction Summary report: N

ID CORE XT

MDR report key: 17265310 · Received July 6, 2023

Report

Report Number
3006413195-2023-00017
Event Type
Malfunction
Date Received
July 6, 2023
Date of Event
April 12, 2023
Report Date
July 6, 2023
Manufacturer
PROGENIKA BIOPHARMA, S.A
Product Code
PEP
UDI-DI
08437013457064
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE GENOMIC DNA SAMPLE WAS SENT TO GRIFOLS LABORATORY SOLUTION FOR DNA SEQUENCING. NEXT GENERATION SEQUENCING INTERROGATED SPECIFIC SEQUENCES: RH PROXIMAL PROMOTER, EXONS 1-10, AND PORTIONS OF INTRON 2-3. THE RH GENOTYPE DETECTED BY SEQUENCING IS A HYBRID SEQUENCE OF RHD EXON2-INTRON2-EXON3 WITHIN RHCE GENE. THIS HYBRID SEQUENCE EXPLAINS THE FAILURE OF ID CORE XT TO DETECT THE 109BP INSERT IN INTRON 2 RESULTING IN A FALSE NEGATIVE PREDICTION OF C ANTIGEN IN DISCREPANCY WITH SEROLOGY RESULT. THE EFFECT OF THIS NOVEL HYBRID ALLELE ON RHCE ANTIGEN EXPRESSION IS UNKNOWN AND FURTHER REVIEW OF SEROLOGY DATA IS RECOMMENDED. THIS FALSE NEGATIVE RESULT OBTAINED BY ID CORE XT IS CONSIDERED A DISCREPANT RESULT AND THEN A MALFUNCTION. THIS CASE REPORT IS ASSOCIATED WITH LIMITATIONS OF ID CORE XT ASSAY DESCRIBED IN THE ID CORE XT PACKAGE INSERT (LIMITATIONS 1 AND 9.7).

Description of Event or Problem · 0

IT WAS REPORTED THAT THE SAMPLE (B)(6), FROM "(B)(6)", WAS TESTED WITH SEROLOGY. THE TEST RESULT WAS POSITIVE (C+), WHICH CONTRASTED WITH THE MOLECULAR TYPING PERFORMED ON (B)(6) 2023, USING THE ID CORE XT ASSAY WHICH PROVIDED NEGATIVE RESULTS (C-) WITH ID CORE XT ANALYSIS SOFTWARE V3.0.2. .

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
989996 ID CORE XT ANTIGEN GENOTYPING TEST PEP PROGENIKA BIOPHARMA, S.A 0203000029 08437013457064

Patients

Seq Age Sex Outcome Treatment
1 Unknown